Ketamine Infusion for Sickle Cell Pain Crisis

Clinical trial NCT04005209 · WITHDRAWN

Trial details

NCT number: NCT04005209
Sponsor: Duke University
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Anemia; Sickle-Cell, With Crisis Acute Pain

Start date: 2022-01-01
Primary completion: 2022-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.